Skip to main content

Beta-ureidopropionase deficiency

Beta-ureidopropionase deficiency



Overview

Beta-ureidopropionase deficiency is a very rare inherited metabolic disorder that affects how the body breaks down pyrimidines (the building blocks of DNA and RNA).

Symptoms

• Neurological & Developmental:

• Hypotonia: Low muscle tone or "floppy" muscle strength.

• Seizures / Epilepsy: Recurrent or unprovoked convulsive episodes.

• Developmental Delay: Lying, sitting, walking, or reaching milestones later than expected.

• Intellectual Disability: Ranging from mild to more pronounced cognitive impairment.

• Speech Difficulties: Delayed language acquisition or articulation issues.

• Autistic Behaviors: Challenges affecting social interaction and communication.

• Physical & Structural:

• Microcephaly: An abnormally small head size in some individuals.

• Brain Abnormalities: Structural variations visible on medical imaging (such as an MRI).

• Optic Nerve Deterioration: Atrophy leading to potential vision loss.

• Asymptomatic Cases:

• A notable portion of individuals with genetic mutations causing this deficiency show no clinical or neurological symptoms and are only identified via incidental laboratory or metabolic screening.

Causes

• Gene Function: The UPB1 gene provides instructions for making the beta-ureidopropionase enzyme.

• Pyrimidine Breakdown: This enzyme performs the final step in breaking down pyrimidines (the building blocks of DNA and RNA). It converts N-carbamyl-beta-aminoisobutyric acid and N-carbamyl-beta-alanine into downstream products like beta-aminoisobutyric acid, beta-alanine, ammonia, and carbon dioxide.

• Enzyme Loss: Mutations in UPB1 reduce or completely eliminate beta-ureidopropionase activity.

• Accumulation & Depletion: This block causes precursor molecules (N-carbamyl-beta-aminoisobutyric acid and N-carbamyl-beta-alanine) to build up and spill into the urine (amino aciduria), while lowering the production of functional beta-alanine and beta-aminoisobutyric acid needed for normal nervous system signaling.

• Autosomal Recessive: The condition is inherited in an autosomal recessive manner, meaning an affected individual must inherit two mutated copies of the UPB1 gene—one from each carrier parent.

• Carriers: Parents who carry a single copy of the mutated gene are typically unaffected and do not show symptoms.

Diagnosis

1. Biochemical Analysis (Urine, Blood, and CSF)

• Urine Screening: Gas chromatography–mass spectrometry (GC–MS) or specialized metabolite analysis shows markedly excessive amounts of N-carbamyl-beta-alanine and N-carbamyl-beta-aminoisobutyric acid.

• Enzyme and Fluid Testing: Reduced or absent activity of the beta-ureidopropionase enzyme can be evaluated, and elevated levels of these precursor molecules may also be detected in plasma or cerebrospinal fluid (CSF).

2. Genetic Testing (UPB1 Gene)

• Molecular Analysis: Confirmed through genetic testing (such as single-gene sequencing or panel/whole-exome sequencing) of the UPB1 gene on chromosome 22q11, which identifies bi-allelic (homozygous or compound heterozygous) pathogenic variants.

• Testing Methods: Performed using blood, saliva, extracted DNA, or buccal swabs via Next-Generation Sequencing (NGS) with deletion/duplication analysis.

3. Supporting Clinical & Imaging Evaluations

• Clinical Evaluation: Assessment for neurological signs such as developmental delay, hypotonia, seizures, speech difficulties, or microcephaly—though some individuals remain completely asymptomatic.

• Diagnostic Imaging and Studies: Head MRI, electroencephalograms (EEG), or metabolic screens may be used to evaluate brain structure, delayed myelination, or rule out overlapping conditions (such as mitochondrial disorders).

Treatment

Because the severity of the condition varies widely—ranging from completely asymptomatic individuals to those with severe neurological symptoms—treatment is tailored to each patient's specific presentation:

• Seizure Control: Anti-seizure medications managed by a neurologist or epileptologist.

• Developmental & Neurological Support: Physical, occupational, and speech therapy to assist with low muscle tone (hypotonia), motor delays, or communication challenges.

• Nutritional & Metabolic Management: Dietary modifications—such as protein or pyrimidine restriction—may be explored alongside targeted supplements (like carnitine) under the guidance of a metabolic specialist. (Note: Direct supplementation with β-alanine has historically shown no clear clinical improvement.)

• Specialist Monitoring: Regular follow-ups with a multidisciplinary team, typically including a geneticist, neurologist, and metabolic specialist, to monitor growth and adjust supportive care

Type of Doctor Department : Neurologist or Epileptologist


Comments

Post a Comment

Popular posts from this blog

Charge Syndrome

Overview CHARGE syndrome is a recognizable genetic syndrome with known pattern of features. It is an extremely complex syndrome, involving extensive medical and physical difficulties that differ from child to child. CHARGE syndrome is correlated with genetic mutation to CHD7 and the prevalence of CHARGE syndrome is 1:10,000-1:15,000 live births. Babies with CHARGE syndrome are often born with life-threatening birth defects. They spend many months in the hospital and undergo many surgeries and other treatments. Swallowing and breathing problems make life difficult even when they come home. Most have hearing two little girls sitting on a carpet, one girl has a trach and is biting her finger.loss, vision loss, and balance problems that delay their development and communication. Despite these seemingly insurmountable obstacles, children with CHARGE syndrome often far surpass their medical, physical, educational, and social expectations. One of the hidden features of CHARGE syndrome is the ...
7 comments
Read more

Dehydration Due to Diarrheal Diseases

Overview Dehydration occurs when you use or lose more fluid than you take in, and your body doesn't have enough water and other fluids to carry out its normal functions. If you don't replace lost fluids, you will get dehydrated. Anyone may become dehydrated, but the condition is especially dangerous for young children and older adults. The most common cause of dehydration in young children is severe diarrhea and vomiting. Older adults naturally have a lower volume of water in their bodies, and may have conditions or take medications that increase the risk of dehydration. This means that even minor illnesses, such as infections affecting the lungs or bladder, can result in dehydration in older adults. Dehydration also can occur in any age group if you don't drink enough water during hot weather — especially if you are exercising vigorously. You can usually reverse mild to moderate dehydration by drinking more fluids, but severe dehydration needs immediate medical treatment. ...
Post a Comment
Read more

Ataxia with Vitamin E Deficiency

Synonyms of Ataxia with Vitamin E Deficiency AVED Familial Isolated Vitamin E Deficiency Isolated Vitamin E Deficiency General Discussion Ataxia with vitamin E deficiency (AVED) is a rare inherited neurodegenerative disorder characterized by impaired ability to coordinate voluntary movements (ataxia) and disease of the peripheral nervous system (peripheral neuropathy). AVED is a progressive disorder that can affect many different systems of the body (multisystem disorder). Specific symptoms vary from case to case. In addition to neurological symptoms, affected individuals may experience eye abnormalities, disorders affecting the heart muscles (cardiomyopathy), and abnormal curvature of the spine (scoliosis). AVED is extremely similar to a more common disorder known as Friedreich’s ataxia. AVED is inherited as an autosomal recessive trait. Vitamin E deficiency often occurs secondary to disorders that impair the absorption of vitamin E from fat including liver disorders, disorders of fat...
Post a Comment
Read more